Arbutus Biopharma Corp. (ABUS)
4.66
+0.07
(+1.53%)
USD |
NASDAQ |
Dec 11, 16:00
4.66
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma EPS Diluted (Quarterly): -0.0404 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Trevi Therapeutics, Inc. | -0.0813 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.742M |
| Revenue (Quarterly) | 0.529M |
| Total Expenses (Quarterly) | 8.271M |
| Enterprise Value | 793.67M |
| Gross Profit Margin (Quarterly) | 97.92% |
| Profit Margin (Quarterly) | -1.46K% |
| Earnings Yield | -4.76% |
| Normalized Earnings Yield | -3.543 |